Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 28,675 |
|
|||||
| News | - | ||||||
| Day High | 5.16 | Low High |
|||||
| Day Low | 4.94 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ImmuCell Corporation | ICCC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.09 | 1.83% | 5.00 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.94 | 4.94 | 5.16 | 5.00 | 4.91 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 155 | 28,675 | US$ 5.04 | US$ 144,481 | - | 4.26 - 6.05 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 100 | US$ 5.00 | USD |
ImmuCell Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 38.75M | 7.75M | - | 17.47M | -5.78M | -0.75 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ImmuCell News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/09/2024 | 15:05 | GlobeNewswire Inc. | ImmuCell Announces Preliminary, Unaudited Sales Results for.. |
| 3/06/2024 | 12:55 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/27/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/27/2024 | 15:05 | GlobeNewswire Inc. | ImmuCell Announces Unaudited Financial Results for the.. |
| 2/16/2024 | 08:30 | GlobeNewswire Inc. | ImmuCell to Announce Unaudited Financial Results for the.. |
| 1/08/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/08/2024 | 15:05 | GlobeNewswire Inc. | ImmuCell Announces Preliminary, Unaudited Sales Results for.. |
| 11/16/2023 | 14:22 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/13/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 15:05 | GlobeNewswire Inc. | ImmuCell Announces Unaudited Financial Results for the.. |
| 11/07/2023 | 11:15 | GlobeNewswire Inc. | ImmuCell to Announce Unaudited Financial Results for the.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ICCC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.94 | 5.20 | 4.82 | 5.01 | 8,798 | 0.06 | 1.21% |
| 1 Month | 5.25 | 5.39 | 4.82 | 5.10 | 8,020 | -0.25 | -4.76% |
| 3 Months | 5.16 | 5.47 | 4.82 | 5.13 | 7,138 | -0.16 | -3.10% |
| 6 Months | 5.04 | 5.64 | 4.34 | 4.99 | 8,706 | -0.04 | -0.79% |
| 1 Year | 4.97 | 6.05 | 4.26 | 5.06 | 11,301 | 0.03 | 0.60% |
| 3 Years | 11.00 | 11.06 | 4.26 | 7.15 | 10,414 | -6.00 | -54.55% |
| 5 Years | 6.32 | 13.20 | 1.71 | 6.72 | 17,101 | -1.32 | -20.89% |
ImmuCell Description
| ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. The company generates the majority of its revenue from the United States. |
